A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis

Molecular and Cellular Proteomics

Volumn 12, Issue 8, 2013, Pages 2111-2125

  Santana Codina, Naiara ^a,b   Carretero, Rafael ^c   Sanz Pamplona, Rebeca ^a   Cabrera, Teresa ^c   Guney, Emre ^d   Oliva, Baldo ^d   Clezardin, Philippe ^e   Olarte, Omar E ^f   Loza Alvarez, Pablo ^f   Méndez Lucas, Andrés ^g   Perales, Jose Carlos ^g   Sierra, Angels ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e INSERM   (France)

^f ICFO INSTITUT DE CIENCIES FOTONIQUES   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA E ANTIGEN; HLA F ANTIGEN; OXIDOREDUCTASE; PROTEIN ERP57; PROTEOME; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIMENTIN; PDIA3 PROTEIN, HUMAN; PROTEIN DISULFIDE ISOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOPLASMIC RETICULUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; ANIMAL; BONE TUMOR; BREAST TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PROTEIN ANALYSIS; SCID MOUSE; SECONDARY; TUMOR CELL LINE;

ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; MICE, SCID; NEOPLASM METASTASIS; PROTEIN DISULFIDE-ISOMERASES; PROTEIN INTERACTION MAPPING; PROTEOME; TRANSCRIPTOME; VIMENTIN;

EID: 84881097831     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.022772     Document Type: Article

References (78)

1. Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordon- Cardo, C., Guise, T. A., and Massagué, J. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549
2. Klein, A., Olendrowitz, C., Schmutzler, R., Hampl, J., Schlag, P. M., Maass, N., Arnold, N., Wessel, R., Ramser, J., Meindl, A., Scherneck, S., and Seitz, S. (2009) Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett. 276, 212-220
3. Minn, A. J., Kang, Y., Serganova, I., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R., and Massagué, J. (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44-55
4. Bellahcène, A., Bachelier, R., Detry, C., Lidereau, R., Clezardin, P., and Castronovo, V. (2007) Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Res. Treat. 101, 135-148
5. Mundy, G. R. (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2, 584-593
6. Gao, D., Nolan, D., McDonnell, K., Vahdat, L., Benezra, R., Altorki, N., and Mittal, V. (2009) Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim. Biophys. Acta 1796, 33-40
7. Garcia, T., Jackson, A., Bachelier, R., Clément-Lacroix, P., Baron, R., Clézardin, P., and Pujuguet, P. (2008) A convenient clinically relevant model of human breast cancer bone metastasis. Clin. Exp. Metastasis 25, 33-42
8. Korpal, M., Yan, J., Lu, X., Xu, S., Lerit, D. A., and Kang, Y. (2009) Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat. Med. 15, 960-966
9. Rosol, T. J., Tannehill-Gregg, S. H., LeRoy, B. E., Mandl, S., and Contag, C. H. (2003) Animal models of bone metastasis. Cancer 97, 748-757
10. Wodak, S. J., Pu, S., Vlasblom, J., and Séraphin, B. (2009) Challenges and rewards of interaction proteomics. Mol. Cell. Proteomics 8, 3-18
11. Wang, Y., Hanley, R., and Klemke, R. L. (2006) Computational methods for comparison of large genomic and proteomic datasets reveal protein markers of metastatic cancer. J. Proteome Res. 5, 907-915
12. Lau, T. Y., Power, K. A., Dijon, S., de Gardelle, I., McDonnell, S., Duffy, M. J., Pennington, S. R., and Gallagher, W. M. (2010) Prioritization of candidate protein biomarkers from an in vitro model system of breast tumor progression toward clinical verification. J. Proteome Res. 9, 1450-1459
13. Auffray, C. (2007) Protein subnetwork markers improve prediction of cancer outcome. Mol Syst Biol 3, 141
14. Chuang, H. Y., Lee, E., Liu, Y. T., Lee, D., and Ideker, T. (2007) Networkbased classification of breast cancer metastasis. Mol. Syst. Biol. 3, 140
15. Peyruchaud, O., Serre, C. M., NicAmhlaoibh, R., Fournier, P., and Clezardin, P. (2003) Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J. Biol. Chem. 278, 45826-45832
16. Aragues, R., Sander, C., and Oliva, B. (2008) Predicting cancer involvement of genes from heterogeneous data. BMC Bioinformatics 9, 172
17. Martin, B., Aragüés, R., Sanz, R., Oliva, B., Boluda, S., Martinez, A., and Sierra, A. (2008) Biological pathways contributing to organ-specific phenotype of brain metastatic cells. J. Proteome Res. 7, 908-920
18. Garcia-Garcia, J., Guney, E., Aragues, R., Planas-Iglesias, J., and Oliva, B. (2010) Biana: a software framework for compiling biological interactions and analyzing networks. BMC Bioinformatics 11, 56
19. Guney, E., Oliva, B. (2012) Exploiting Protein-Protein Interaction Networks for Genome-Wide Disease-Gene Prioritization. PLoS OneVolume 7 Issue 9
20. Aragues, R., Jaeggi, D., and Oliva, B. (2006) PIANA: protein interactions and network analysis. Bioinformatics 22, 1015-1017
21. Méndez, O., Fernández, Y., Peinado, M. A., Moreno, V., and Sierra, A. (2005) Anti-Apoptotic proteins induce non-random genetic alterations that result in selecting breast cancer metastatic cells. Clin. Exp. Metastasis 22, 297-307
22. North, B. V., Curtis, D., and Sham, P. C. (2002) A Note on the Calculation of Empirical P Values from Monte Carlo Procedures. Am. J. Hum. Genet. 71, 439-441
23. Ewens, W. J. (2003) On estimating P Values by Monte Carlo Methods. Am. J. Hum. Genet. 72, 496-498
24. van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536
25. Garrido, F., Cabrera, T., Accolla, R. S., Bensa, J. C., Bodmer, W., Dohr, G., Drouet, M., Fauchet, R., Ferrara, G. B., Ferrone, S., Giacomini, P., Kageshita, T., Koopman, L., Maio, M., Marincola, F., Mazzilli, C., Morel, P. A., Murray, A., Papasteriades, Crh., Salvaneschi, L., Stern, P. L., and Ziegler, A. (1997) HLA and cancer: 12th International Histocompatibility Workshop study. HLA, Genetic diversity of HLA. Functional and Medical Implications. Ed. by D. Charron, EDK Publisher, vol. I, 445-452
26. Carretero, R., Romero, J. M., Ruiz-Cabello, F., Maleno, I., Rodriguez, F., Camacho, F. M., Real, L. M., Garrido, F., and Cabrera, T. (2008) Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy. Immunogenetics 60, 439-447
27. Romero, J. M., Jiménez, P., Cabrera, T., Cózar, J. M., Pedrinaci, S., Tallada, M., Garrido, F., and Ruiz-Cabello, F. (2005) Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Int. J. Cancer 113, 605-610
28. Maleno, I., Romero, J. M., Cabrera, T., Paco, L., Aptsiauri, N., Cozar, J. M., Tallada, M., López-Nevot, M. A., and Garrido, F. (2006) LOH at 6p3 region and HLA class I altered phenotypes in bladder carcinomas. Immunogenetics 58, 503-510
29. Koene, G. J., Arts-Hilkes, Y. H., van der Ven, K. J., Rozemuller, E. H., Slootweg, P. J., de Weger, R. A., and Tilanus, M. G. (2004) High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis. Tissue Antigens 64, 452-461
30. Kanof, M., and Smith, P. (1991) Preparation of human mononuclear cell populations and subpopulations. Coligan, J., et al., editors. Current Protocols in Immunology. New York: Green Publication Associates and Wiley-Interscience; 1991, 711-715
31. Kischel, P., Guillonneau, F., Dumont, B., Bellahcene, A., Stresing, V., Clézardin, P., De Pauw, E. A., and Castronovo, V. (2008) Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells. Neoplasia 10, 1014-1020
32. Nevins, J. R., Huang, E. S., Dressman, H., Pittman, J., Huang, A. T., and West, M. (2003) Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet 12, R153-R157
33. Naderi, A., Teschendorff, A. E., Barbosa-Morais, N. L., Pinder, S. E., Green, A. R., Powe, D. G., Robertson, J. F., Aparicio, S., Ellis, I. O., Brenton, J. D., and Caldas, C. (2007) A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 26, 1507-1516
34. Feng, Y., Sun, B., Li, X., Zhang, L., Niu, Y., Xiao, C., Ning, L., Fang, Z., Wang, Y., Zhang, L., Cheng, J., Zhang, W., and Hao, X. (2007) Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res. Treat 103, 319-329
35. Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., Jatkoe, T., Berns, E. M., Atkins, D., and Foekens, J. A. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679
36. Chapman, D. C., and Williams, D. B. (2010) ER quality control in the biogenesis of MHC class I molecules. Semin. Cell Dev. Biol. 21, 512-519
37. Aptsiauri, N., Cabrera, T., Garcia-Lora, A., Lopez-Nevot, M. A., Ruiz-Cabello, F., and Garrido, F. (2007) MHC class I antigens and immune surveillance in transformed cells. Int. Rev. Cytol. 256, 139-189
38. Stresing, V., Baltziskueta, E., Rubio, N., Blanco, J., Arriba, M., Valls, J., Janier, M., Clezardin, P., Sanz-Pamplona, R., Nieva, C., Marro, M., Dmitri, P., and Sierra, A. (2013) Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene 32, 724-735
39. Garbi, N., Tanaka, S., Momburg, F., and Hämmerling, G. J. (2006) Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp. Nat. Immunol. 7, 93-102
40. Granados, D. P., Tanguay, P. L., Hardy, M. P., Caron, E., de Verteuil, D., Meloche, S., and Perreault, C. (2009) ER stress affects processing of MHC class I-Associated peptides. BMC Immunol. 10, 10
41. Polyak, K., and Weinberg, R. A. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273
42. Elanchezhian, R., Palsamy, P., Madson, C. J., Mulhern, M. L., Lynch, D. W., Troia, A. M., Usukura, J., and Shinohara, T. (2012) Low glucose under hypoxic conditions induces unfolded protein response and produces reactive oxygen species in lens epithelial cells. Cell Death Dis. 3, e301
43. High, S., Lecomte, F. J., Russell, S. J., Abell, B. M., and Oliver, J. D. (2000) Glycoprotein folding in the endoplasmic reticulum: a tale of three chaperones? FEBS Lett. 476, 38-41
44. Furney, S. J., Higgins, D. G., Ouzounis, C. A., and López-Bigas, N. (2006) Structural and functional properties of genes involved in human cancer. BMC Genomics 7, 3
45. Kar, G., Gursoy, A., and Keskin, O. (2009) Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol 5, e1000601
46. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E. (2000) The Protein Data Bank. Nucleic Acids Res. 28, 235-242
47. Ogmen, U., Keskin, O., Aytuna, A. S., Nussinov, R., and Gursoy, A. (2005) PRISM: protein interactions by structural matching. Nucleic Acids Res. 33, W331-W336
48. Tsai, Y. C., and Weissman, A. M. (2010) The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer. Genes Cancer 1, 764-778
49. Xu, D., Perez, R. E., Rezaiekhaligh, M. H., Bourdi, M., and Truog, W. E. (2009) Knockdown of ERp57 increases BiP/GRP78 induction and protects against hyperoxia and tunicamycin-induced apoptosis. Am. J. Physiol. Lung Cell Mol Physiol 297, L44-L51
50. Grillo, C., D'Ambrosio, C., Scaloni, A., Maceroni, M., Merluzzi, S., Turano, C., and Altieri, F. (2006) Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors. Free Radic. Biol. Med. 41, 1113-1123
51. Ramirez-Rangel, I., Bracho-Valdés, I., Vazquez-Macias, A., Carretero-Ortega, J., Reyes-Cruz, G., and Vázquez-Prado, J. (2011) Regulation of mTORC1 complex assembly and signaling by GRp58/ERp. Mol. Cell. Biol. 31, 1657-1671
52. Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., Wang, S., Ren, P., Martin, M., Jessen, K., Feldman, M. E., Weissman, J. S., Shokat, K. M., Rommel, C., and Ruggero, D. (2012) The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485, 55-61
53. Coe, H., Jung, J., Groenendyk, J., Prins, D., and Michalak, M. (2010) ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum. J. Biol. Chem. 285, 6725-6738
54. Liao, C. J., Wu, T. I., Huang, Y. H., Chang, T. C., Wang, C. S., Tsai, M. M., Lai, C. H., Liang, Y., Jung, S. M., and Lin, K. H. (2011) Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer. Cancer Sci. 102, 2255-2263
55. Brubaker, K. D., Corey, E., Brown, L. G., and Vessella, R. L. (2004) Bone morphogenetic protein signaling in prostate cancer cell lines. J. Cell. Biochem. 91, 151-160
56. Cicchillitti, L., Della Corte, A., Di Michele, M., Donati, M. B., Rotilio, D., and Scambia, G. (2010) Characterisation of a multimeric protein complex associated with ERp57 within the nucleus in paclitaxel-sensitive and -resistant epithelial ovarian cancer cells: the involvement of specific conformational states of beta-Actin. Int. J. Oncol. 37, 445-454
57. Cicchillitti, L., Di Michele, M., Urbani, A., Ferlini, C., Donat, M. B., Scambia, G., and Rotilio, D. (2009) Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of Erp. J. Proteome Res. 8, 1902-1912
58. Hishiya, A., and Takayama, S. (2008) Molecular chaperones as regulators of cell death. Oncogene 27, 6489-6506
59. Zhang, Y., Baig, E., and Williams, D. B. (2006) Functions of ERp57 in the folding and assembly of major histocompatibility complex class I molecules. J. Biol. Chem. 281, 14622-14631
60. Kienast, A., Preuss, M., Winkler, M., and Dick, T. P. (2007) Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin. Nat. Immunol. 8, 864-872
61. Wearsch, P. A., and Cresswell, P. (2008) The quality control of MHC class I peptide loading. Curr. Opin. Cell Biol. 20, 624-631
62. Peaper, D. R., and Cresswell, P. (2008) Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell Dev. Biol. 24, 343-368
63. Hansen, T. H., and Bouvier, M. (2009) MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9, 503-513
64. Paulsson, K. M., Kleijmeer, M. J., Griffith, J., Jevon, M., Chen, S., Anderson, P. O., Sjogren, H. O., Li, S., and Wang, P. (2002) Association of tapasin and COPI provides a mechanism for the retrograde transport of major histocompatibility complex (MHC) class I molecules from the Golgi complex to the endoplasmic reticulum. J. Biol. Chem. 277, 18266-18271
65. Rutkevich, L. A., Cohen-Doyle, M. F., Brockmeier, U., and Williams, D. B. (2010) Functional relationship between protein disulfide isomerase family members during the oxidative folding of human secretory proteins. Mol. Biol. Cell 21, 3093-3105
66. Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., and Stern, P. L. (1993) Natural history of HLA expression during tumour development. Immunol. Today 14, 491-499
67. Algarra, I., Garcia-Lora, A., Cabrera, T., Ruiz-Cabello, F., and Garrido, F. (2004) The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother 53, 904-910
68. Rodriguez, T., Aptsiauri, N., Mendez, R., Jimenez, P., Ruiz-Cabello, F., and Garrido, F. (2007) Different mechanisms can lead to the same altered HLA class I phenotype in tumors. Tissue Antigens 69, 259-263
69. Sabapathy, K., and Nam, S. Y. (2008) Defective MHC class I antigen surface expression promotes cellular survival through elevated ER stress and modulation of p53 function. Cell Death Differ. 15, 1364-1374
70. (2000) Adjuvant therapy for breast cancer. NIH Consens Statement 17, 1-35
71. Hortobagyi, G. N. (2000) Developments in chemotherapy of breast cancer. Cancer 88, 3073-3079
72. Barnstable, C. J., Jones, E. A., and Crumpton, M. J. (1978) Isolation, structure and genetics of HLA-A, -B, -C and -DRw (Ia) antigens. Br. Med. Bull. 34, 241-246
73. Lampson, L. A., Fisher, C. A., and Whelan, J. P. (1983) Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines. J. Immunol. 130, 2471-2478
74. Lopez Nevot, M. A., Ruiz-Cabello, F., Huelin, C., Cabrera, A., and Garrido, F. (1986) [A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia]. Sangre 31, 751-758
75. Lozano, F., Santos-Aguado, J., Borche, L., Places, L., Doménech, N., Gayá, A., Vilella, R., and Vives, J. (1989) Identification of the amino acid residues defining an intralocus determinant in the alpha 1 domain of HLA-A molecules. Immunogenetics 30, 50-53
76. Lozano, F., Borche, L., Places, L., Alberola-Ila, J., Gaya, A., Vilella, R., and Vives, J. (1990) Biochemical and serological characterization of a public antigenic determinant present on HLA-B molecules. Tissue Antigens 35, 193-195
77. Stam, N. J., Vroom, T. M., Peters, P. J., Pastoors, E. B., and Ploegh, H. L. (1990) HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int. Immunol. 2, 113-125
78. Radka, S. F., Kostyu, D. D., and Amos, D. B. (1982) A monoclonal antibody directed against the HLA-Bw6 epitope. J. Immunol. 128, 2804-2806